The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Ospedale Sant’Anna de Turín
Due to the donation received from Diasorin, i4c could purchase three medical devices for Hospital Sant’Anna in Turin (Italy). They are a total body cooling, a UTIN and a non…
see project
